SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on August 3, 2010. The filing reports the consolidated financial results for the fourth quarter and the full fiscal year 2010, which ended on May 30, 2010. The detailed results are contained in a press release attached as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1), which is not part of the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the announcement of results for the period ended May 30, 2010.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The document serves primarily as a notice that the press release containing this information has been issued.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific revenue, net income, and cash flow figures for Q4 and FY 2010.
- Verify the company name discrepancy: The filing header lists "Landec Corporation," while the request metadata mentions "LIFECORE BIOMEDICAL, INC." Confirm the correct registrant identity.
- Check for any forward-looking statements or guidance included in the full text of the August 3, 2010 press release.
- Confirm the fiscal year-end date of May 30, 2010, for accurate period-over-period comparisons.